AAPL   269.39 (-0.49%)
FB   202.30 (+0.62%)
MSFT   151.99 (+0.16%)
GOOGL   1,352.17 (+0.95%)
AMZN   1,763.38 (+0.67%)
NVDA   213.68 (+0.71%)
MU   47.17 (-1.61%)
GE   11.06 (-0.36%)
TSLA   338.50 (+0.78%)
T   38.31 (+0.29%)
AMD   39.78 (+0.38%)
ACB   2.53 (+4.12%)
F   9.01 (-0.11%)
PRI   134.96 (-0.53%)
NFLX   308.19 (+0.27%)
BAC   33.62 (-0.15%)
GILD   67.32 (+0.36%)
DIS   147.97 (+0.21%)
AAPL   269.39 (-0.49%)
FB   202.30 (+0.62%)
MSFT   151.99 (+0.16%)
GOOGL   1,352.17 (+0.95%)
AMZN   1,763.38 (+0.67%)
NVDA   213.68 (+0.71%)
MU   47.17 (-1.61%)
GE   11.06 (-0.36%)
TSLA   338.50 (+0.78%)
T   38.31 (+0.29%)
AMD   39.78 (+0.38%)
ACB   2.53 (+4.12%)
F   9.01 (-0.11%)
PRI   134.96 (-0.53%)
NFLX   308.19 (+0.27%)
BAC   33.62 (-0.15%)
GILD   67.32 (+0.36%)
DIS   147.97 (+0.21%)
AAPL   269.39 (-0.49%)
FB   202.30 (+0.62%)
MSFT   151.99 (+0.16%)
GOOGL   1,352.17 (+0.95%)
AMZN   1,763.38 (+0.67%)
NVDA   213.68 (+0.71%)
MU   47.17 (-1.61%)
GE   11.06 (-0.36%)
TSLA   338.50 (+0.78%)
T   38.31 (+0.29%)
AMD   39.78 (+0.38%)
ACB   2.53 (+4.12%)
F   9.01 (-0.11%)
PRI   134.96 (-0.53%)
NFLX   308.19 (+0.27%)
BAC   33.62 (-0.15%)
GILD   67.32 (+0.36%)
DIS   147.97 (+0.21%)
AAPL   269.39 (-0.49%)
FB   202.30 (+0.62%)
MSFT   151.99 (+0.16%)
GOOGL   1,352.17 (+0.95%)
AMZN   1,763.38 (+0.67%)
NVDA   213.68 (+0.71%)
MU   47.17 (-1.61%)
GE   11.06 (-0.36%)
TSLA   338.50 (+0.78%)
T   38.31 (+0.29%)
AMD   39.78 (+0.38%)
ACB   2.53 (+4.12%)
F   9.01 (-0.11%)
PRI   134.96 (-0.53%)
NFLX   308.19 (+0.27%)
BAC   33.62 (-0.15%)
GILD   67.32 (+0.36%)
DIS   147.97 (+0.21%)
Log in

OTCMKTS:NWCI - Newcardio Stock Price, Forecast & News

$0.0033
0.00 (0.00 %)
(As of 12/9/2019 10:03 AM ET)
Today's Range
$0.00
Now: $0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00
$0.01
Volume12,000 shs
Average Volume5,326 shs
Market Capitalization$134,673.00
P/E RatioN/A
Dividend YieldN/A
Beta6.23
NewCardio, Inc., a cardiac diagnostic and services company, focuses on the research, development, and commercialization of proprietary software platform technology solutions for the non-invasive diagnosis and monitoring of cardiovascular disease (CVD), as well as the cardiac safety assessment of drugs under development. The company's technology platform provides real-time and 3-D analysis of the heart's electrical activity as detected at the body surface by standard 12-lead electrocardiogram (ECG) electrodes. Its developing products include QTinno, an automated cardiac safety solution that replaces the manual and/or semi-automated methodologies with algorithms that automatically measure, analyze, and report on the ECGs collected; and CardioBip, a mobile ECG transtelephonic system comprising a mobile ECG recording and transmitting device, and a Web enabled software which receives, processes, and analyzes the data. The company is also developing my3KG, a software application to provide a method to assess cardiac electrical activity in time and space. NewCardio, Inc. was founded in 2004 and is based in Branchburg, New Jersey.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:NWCI
CUSIPN/A
CIKN/A
Phone510-774-1969

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees10
Market Cap$134,673.00
Next Earnings DateN/A
OptionableNot Optionable

Receive NWCI News and Ratings via Email

Sign-up to receive the latest news and ratings for NWCI and its competitors with MarketBeat's FREE daily newsletter.


Newcardio (OTCMKTS:NWCI) Frequently Asked Questions

What is Newcardio's stock symbol?

Newcardio trades on the OTCMKTS under the ticker symbol "NWCI."

Has Newcardio been receiving favorable news coverage?

Media stories about NWCI stock have been trending somewhat negative on Monday, InfoTrie reports. The research group rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Newcardio earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the next several days. View News Stories for Newcardio.

Who are some of Newcardio's key competitors?

What other stocks do shareholders of Newcardio own?

Who are Newcardio's key executives?

Newcardio's management team includes the folowing people:
  • Dr. Jess Emery Jones M.D., CEO & Director (Age 40)
  • Mr. Greg Sadowski, Chief Operating Officer

How do I buy shares of Newcardio?

Shares of NWCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Newcardio's stock price today?

One share of NWCI stock can currently be purchased for approximately $0.00.

How big of a company is Newcardio?

Newcardio has a market capitalization of $134,673.00. Newcardio employs 10 workers across the globe.View Additional Information About Newcardio.

What is Newcardio's official website?

The official website for Newcardio is http://www.newcardio.com/.

How can I contact Newcardio?

Newcardio's mailing address is 2350 MISSION COLLEGE BLVD. #1175, SANTA CLARA CA, 95054. The company can be reached via phone at 510-774-1969 or via email at [email protected]


MarketBeat Community Rating for Newcardio (OTCMKTS NWCI)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  34 (Vote Outperform)
Underperform Votes:  32 (Vote Underperform)
Total Votes:  66
MarketBeat's community ratings are surveys of what our community members think about Newcardio and other stocks. Vote "Outperform" if you believe NWCI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NWCI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/9/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel